Apollon Wealth Management LLC Trims Position in UnitedHealth Group Incorporated $UNH

Apollon Wealth Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 15.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,541 shares of the healthcare conglomerate’s stock after selling 4,968 shares during the period. Apollon Wealth Management LLC’s holdings in UnitedHealth Group were worth $8,592,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Citizens National Bank Trust Department increased its position in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after purchasing an additional 170 shares during the period. Caitlin John LLC increased its position in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 111 shares during the period. Triumph Capital Management purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $1,324,000. Wealth Effects LLC grew its position in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after buying an additional 591 shares during the last quarter. Finally, Arlington Partners LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $2,229,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $354.30 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a 50 day simple moving average of $318.21 and a two-hundred day simple moving average of $349.25. The stock has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The business’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday. Wells Fargo & Company lifted their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Hold” and an average price target of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.